Jeffrey P. George has bought stock on 2 days since May 2020

Jeffrey P. George (also known as Jeff George) is the Chairperson of the Board of Directors at LENZ Therapeutics, Inc. (NASDAQ: LENZ), a late-stage biopharmaceutical company developing aceclidine-based eye drops for presbyopia.( He recently engaged in securities transactions as a director of the company, with his address listed at LENZ's Solana Beach, CA headquarters.(

George is the Managing Partner and founder of Maytal Capital, a healthcare-focused venture capital and private equity firm established in 2017.( His career highlights include serving as global CEO of Sandoz (Novartis's generics division) and Alcon (eye care division) from 2008 to 2016, both on Novartis's Executive Committee, with each generating around $10 billion in revenue at the time.( He holds board positions at Amneal Pharmaceuticals (NASDAQ: AMRX), 908 Devices (NASDAQ: MASS), and others, and previously chaired Lykos Therapeutics.( George earned an MBA from Harvard Business School, a Master's from Johns Hopkins SAIS, and a B.A. from Carleton College.(

Written by Perplexity from public sources.